Measuring response with FDG-PET: Methodological aspects

Martin Allen-Auerbach, Wolfgang A. Weber

Research output: Contribution to journalArticlepeer-review

53 Scopus citations


The use of fluorodeoxyglucose positron emission tomography (FDG-PET) for the evaluation of tumor response to chemotherapy and radiation therapy has been studied in a number of malignancies. By imaging tumor metabolism and therapy-related changes, FDG-PET has demonstrated advantages over anatomical imaging in the assessment of treatment response. More recent investigations have indicated that FDG-PET can predict tumor response early during the course of therapy, potentially allowing for early treatment adjustments. The aim of this review is to provide oncologists with a basic knowledge of the practical aspects of PET quantification for treatment.

Original languageEnglish
Pages (from-to)369-377
Number of pages9
Issue number4
StatePublished - Apr 2009
Externally publishedYes


  • Chemotherapy
  • Fluorodeoxyglucose
  • Positron emission tomography
  • Radiotherapy
  • Response


Dive into the research topics of 'Measuring response with FDG-PET: Methodological aspects'. Together they form a unique fingerprint.

Cite this